Blueprint for Transparency at the U.S. Food and Drug Administration
Researchers from the Johns Hopkins Bloomberg School of Public Health, Brigham and Women’s Hospital/Harvard Medical School, Yale Medical School, and Yale Law School have developed a report with recommendations to increase transparency at the U.S. Food and Drug Administration. The goal of the recommendations is to advance the development of safe and effective medical products in the United States.
Read the Blueprint, which has been accepted for publication later this year in the Journal of Law, Medicine & Ethics, Volume 45, Number 4.
This project is supported by a grant from the Laura and John Arnold Foundation.